Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 14Prostatic Neoplasms 3Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Vaginal Neoplasms 2Pancreatic Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Vulvar Neoplasms 1Uveitis 1Uveal Melanoma 1Sarcoma 1Precancerous Conditions 1Papillomavirus Infections 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Malignant mesenchymal tumor 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Esophageal Squamous Cell Carcinoma 1Desmoplastic Small Round Cell Tumor 1Choroid Neoplasms 1Carcinosarcoma 1Carcinoma, Ovarian Epithelial 1

Interventions

tremelimumab 2pembrolizumab 2Radiofrequency Ablation 2Oxaliplatin 2Cryosurgery 2Capecitabine 2trametinib 1durvalumab 1Tomography, X-Ray Computed 1Radiation 1Positron-Emission Tomography 1Magnetic Resonance Imaging 1Hydroxychloroquine 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Biliary Tract Neoplasms × Brachytherapy × Clear all
NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 13 charts
GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡